GLG Pharma SA logo

GLG - GLG Pharma SA Share Price

PLN0.58 -0.0  -1.0%

Last Trade - 03/06/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 747
Bullish
Bearish
Unlock GLG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GLG Revenue Unlock GLG Revenue

Net Income

GLG Net Income Unlock GLG Revenue

Normalised EPS

GLG Normalised EPS Unlock GLG Revenue

PE Ratio Range

GLG PE Ratio Range Unlock GLG Revenue

Dividend Yield Range

GLG Dividend Yield Range Unlock GLG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GLG EPS Forecasts Unlock GLG Revenue
Profile Summary

GLG Pharma SA is a Poland-based company engaged in the biotechnology sector. The Company focuses on the research and development of therapies based on small molecules and formulations, which inhibit dysfunctional Signal Transducer and Activators of Transcription (STAT3) signaling. STAT3 is a signaling protein, which optimizes the human cell growth. The Company develops projects related to cancer and kidney disease treatment, as well as other drug applications. Its pipeline includes STAT3 inhibitors that mainly aim at treatment of chronic lymphatic leukemia (CLL), polycystic kidney disease (PKD) and triple negative breast cancer (TNBC). The Company performs clinical trials in laboratories located in Poland and the United States.

Directors
Last Annual December 31st, 2018
Last Interim March 31st, 2019
Incorporated May 23, 2011
Public Since February 6, 2012
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Warsaw Stock Exchange
Shares in Issue 8,800,001
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GLG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GLG
Upcoming Events for GLG
Similar to GLG
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.